Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, China.
J Am Soc Nephrol. 2011 Oct;22(10):1897-911. doi: 10.1681/ASN.2010080822. Epub 2011 Sep 8.
Cells residing in the hypertonic, hypoxic renal medulla depend on dynamic adaptation mechanisms to respond to changes in energy supply and demand. The serine/threonine kinase 5'-AMP protein kinase (AMPK) is a sensor of cellular energy status, but whether it contributes to the survival of cells in the renal medulla is unknown. Here, hypertonic conditions induced a decrease in AMPK phosphorylation within 12 hours in renal medullary interstitial cells (RMIC), followed by a gradual return to baseline levels. Activation of AMPK markedly increased hypertonicity-induced apoptosis of RMICs and suppressed both hypertonicity-induced NFκB nuclear translocation and cyclooxygenase-2 (COX-2) activation; overexpression of COX-2 significantly attenuated these effects. AMPK activation also markedly reduced generation of reactive oxygen species and nuclear expression of tonicity-responsive enhancer-binding protein, which prevented upregulation of osmoprotective genes. In vivo, pharmacologic activation of AMPK led to massive apoptosis of RMICs and renal dysfunction in the setting of water deprivation in mice. Taken together, these results identify a critical role for AMPK in the maintenance of RMIC viability and suggest that AMPK modulates the NFκB-COX-2 survival pathway in the renal medulla. Furthermore, this study raises safety concerns for the development of AMPK activators as anti-diabetic drugs, especially for patients prone to dehydration.
驻留在高渗、缺氧的肾髓质中的细胞依赖于动态适应机制来响应能量供应和需求的变化。5'-AMP 蛋白激酶(AMPK)是细胞能量状态的传感器,但它是否有助于肾髓质细胞的存活尚不清楚。在这里,高渗条件在 12 小时内诱导肾髓质间质细胞(RMIC)中 AMPK 磷酸化减少,随后逐渐恢复到基线水平。AMPK 的激活显著增加了 RMIC 的高渗诱导凋亡,并抑制了高渗诱导的 NFκB 核易位和环氧化酶-2(COX-2)的激活;COX-2 的过表达显著减弱了这些作用。AMPK 的激活还显著减少了活性氧的产生和张力应答增强子结合蛋白的核表达,从而防止了渗透保护基因的上调。在体内,AMPK 的药理学激活导致了水剥夺小鼠 RMIC 大量凋亡和肾功能障碍。总之,这些结果表明 AMPK 在维持 RMIC 活力方面起着关键作用,并表明 AMPK 调节了肾髓质中的 NFκB-COX-2 存活途径。此外,这项研究对 AMPK 激活剂作为抗糖尿病药物的开发提出了安全方面的担忧,特别是对容易脱水的患者。